A Multi-Center Phase II Study to Compare MER-101 (20mg) Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00636740

Locations


United States, Alabama
	Birmingham Hematology & Oncology Associates, LLC	Recruiting
	Birmingham, Alabama, United States, 35223
	Contact: Jimmie Harvey, MD 205-592-5077
	Contact: Kevin Windsor, MD 205-592-5077
	Principal Investigator: Jimmie Harvey, MD

United States, Florida
	Lakeland Regional Cancer Center	Recruiting
	Lakeland, Florida, United States, 33805
	Contact: G. Byron Hodge, Jr., MD 863-904-1900
	Contact: Robert H. Cassell, MD, PhD 863-904-1900
	Principal Investigator: G. Byron Hodge, Jr., MD
	Cancer Care of North Florida, P.A.	Recruiting
	Lake City, Florida, United States, 32055
	Contact: Waseem Khan, MD 386-755-1655
	Contact: Sheila Roberts, ARNP 386-755-1655
	Principal Investigator: Waseem Khan, MD
	Innovative Medical Research of South Florida, Inc.	Recruiting
	Miami, Florida, United States, 33179
	Contact: Marc A. Saltzman, MD 305-759-1881
	Contact: Bojana B Bhardwaj, MD 305-759-1881
	Principal Investigator: Marc A. Saltzman, MD

United States, Louisiana
	Green Clinic, LLC	Recruiting
	Ruston, Louisiana, United States, 71270
	Contact: David C. Osafo, MD 318-251-6352
	Principal Investigator: David C. Osafo, MD

United States, New York
	New York Urological Associates, PC	Recruiting
	New York, New York, United States, 10022
	Contact: John A Fracchia, MD 212-570-6800
	Contact: Noel A Armenakas, MD 212-570-6800
	Principal Investigator: John A Fracchia, MD

United States, South Carolina
	Charleston Hematology Oncology Associates, PA	Recruiting
	Charleston, South Carolina, United States, 29403
	Contact: George F Geils Jr, MD 843-577-6957
	Contact: David M Ellison, MD 843-577-6957
	Principal Investigator: George F Geils Jr, MD

United States, Virginia
	Cancer Outreach Associates, P.C.	Recruiting
	Abingdon, Virginia, United States, 24211
	Contact: Maureen Ross, MD 276-676-1860
	Contact: Thomas Johnson, MD 276-676-1860
	Principal Investigator: Maureen Ross, MD

Sponsors and Collaborators

Merrion Pharmaceuticals, LLC